Trump’s head of the Department of Health and Human Services allegedly, traded stocks of health-related companies while working on legislation affecting the same firms. Insiders says Bharara was overseeing an investigation.
Price maintains that he broke no laws when he traded health care stocks even as he was involved in legislation relevant to the health care sector. He traded over $300,000 worth of shares of relevant companies during a four-year period in the House.
The issue played a significant role in Price’s confirmation process, and he was asked about it numerous times during his Senate hearing.
The revelation that Bharara was investigating Price comes as many were surprised the US attorney from the Southern District of New York a carryover from the previous Democratic administration was not retained by the in-coming Trump administration.
Copyright © 2023